Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $13.9100 (-1.07%) ($13.7000 - $14.0600) on Thu. Apr. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.23% (three month average) | RSI | 50 | Latest Price | $13.9100(-1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.7% a day on average for past five trading days. | Weekly Trend | FOLD advances 0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(61%) XBI(57%) IWO(55%) IWM(52%) IWC(50%) | Factors Impacting FOLD price | FOLD will decline at least -1.615% in a week (0% probabilities). VXX(-14%) TLT(-14%) UUP(-13%) VIXM(-8%) IFRA(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.615% (StdDev 3.23%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $13.74(1.24%) | 10 Day Moving Average | $13.55(2.66%) | 20 Day Moving Average | $13.56(2.58%) | To recent high | -1.1% | To recent low | 27.7% | Market Cap | $3.592b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |